The Latest Breaking News from Influenza

Washington (AFP) - US biotech company Moderna said Thursday it had mixed results from a large-scale trial of its mRNA flu shot, based on the same technology used in its successful Covid-19 vaccine.

A highly pathogenic strain of bird flu is decimating poultry, wild birds and other animals in many parts of the world, driving some countries to consider vaccination.

A strain of avian influenza, H5N1, has been reported in mammals. While there's fear the virus may jump to humans next, experts say the risk is low.

It is rising fast as a contender amid dramatic outbreaks among mammals, and could be far deadlier than COVID-19.

Millions of birds have died from a new strain of avian flu sweeping the globe, and while it has not been detected in Australia yet, experts are worried the virus also has been found in mammals.

Three animals in Colorado, each of them now dead, tested positive for the highly pathogenic avian influenza that’s sweeping across the country, state wildlife officials said in a release.

How do you make a universal flu vaccine? A microbiologist explains the challenges and how mRNA could offer a promising solution

The host cell's molecular arsenal is used by viruses to multiply. Read full report of Dynamite News:

The recent spread to mammals of H5N1 influenza - commonly known as bird flu - needs to be monitored, but the risk to humans remains low, the World Health Organization said on Wednesday. H5N1 has spread among poultry and wild birds for 25 years, Director-general Tedros Adhanom Ghebreyesus told reporters…

To everything there is a season, and for the flu, it’s wintertime. Flu cases peak between December and February, and the flu vaccine is your best defense. Getting the vaccine means you will be less sick even if you get a breakthrough infection.

The question of whether and to what extent face masks work to prevent respiratory infections such as COVID and influenza has split the scientific community for decades.